Global Healthcare and Medical Simulation
Global Healthcare and Medical Simulation

Healthcare and Medical Simulation Comprehensive Study by Category (Low-fidelity simulators, Medium-fidelity simulators, High-fidelity simulators), Industry Vertical (Military, Commercial airlines, Nuclear power plants, Business and medicine, Others), End Use (Pediatricians, Pediatric subspecialists, Pediatric nurses, Educators, Others) Players and Region - Global Market Outlook to 2026

Healthcare and Medical Simulation Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Dec 2021 Edition 213 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Healthcare and Medical Simulation Market Scope
Healthcare and medical Simulation is the modern mode to train healthcare professionals in order to master the technical, and behavioral skills through technologically advanced crafted experiences. It helps to build experiential learning that enables professionals and learners to practice and test their profession while building confidence in their abilities, prior to working in the real world scenario. Geographically, North America is the leading region for medical and healthcare simulation programs due to rapid urbanization and more awareness about the effective disease that is propelling the growth of the market in the upcoming year. The demand for the market is huge that is driving the growth of the market over the forecast period

The Healthcare and Medical Simulation market study is segmented and major geographies with country level break-up.

The market is expected to grow in the training and education sector. It has wide applications in inpatient simulation, surgical simulation, and ultrasound simulation, and clinical. Several companies such MedAffinity, Laerdal, Gaumard are operating in the market to provide customers with better offer with various features & unique offerings. The market is partially fragmented market with the presence of several market players and local players. The demand for the market is huge that is triggering the market growth over the forecast period.

MedAffinity (United States), Laerdal (Norway), Kyoto Kagaku Co., Ltd (China), Gaumard (United States), MedVision (Germany), Limbs and things (United Kingdom), KbPort LLC (United States), International Pediatric Simulation Society (United States), DiaMedical (United States), Simulab Corporation (United States), Ford Audio-Video (United States), Medical-X (Netherlands), CAE Healthcare (Canada), AUGMENT SIMULATION (Canada), Intelligent Ultrasound (United Kingdom), Nasco Healthcare (United States) and Others are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AMA Research has segmented the market of Global Healthcare and Medical Simulation market by Type, Application and Region.

On the basis of geography, the market of Healthcare and Medical Simulation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
On December 2020 Elsevier has acquires Shadow Health, thta is the leading provider of best-in-class healthcare simulations
On September 2021, the Medical Simulation Center has inaugurated at Apollo Hospital., and On May 2021 NEJM Group, EMS has Launch Healthcare Simulation Program


Market Trend
  • Rising demand for e-health application

Market Drivers
  • It Provides Hands-On Training without Risk

Opportunities
  • Huge demand in virtual training in health and medical simulation that is cost-effective and time-saving

Restraints
  • The training cost is expensive

Challenges
  • Detection of disease at an early stage helps not only to reduce the cost of medical treatment but is also useful in saving valuable lives of people


Key Target Audience
Supplier, OEM (Original Equipment Manufacturer), Regulatory Authorities, New Entrants/Investors, Strategic Business Planners, Governments and End-Use Industry

Frequently Asked Questions (FAQ):

1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.

2. How big is the Healthcare and Medical Simulation Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.

Report Objectives / Segmentation Covered
By Category
  • Low-fidelity simulators
  • Medium-fidelity simulators
  • High-fidelity simulators

By Industry Vertical
  • Military
  • Commercial airlines
  • Nuclear power plants
  • Business and medicine
  • Others

By End Use
  • Pediatricians
  • Pediatric subspecialists
  • Pediatric nurses
  • Educators
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. It Provides Hands-On Training without Risk
    • 3.3. Market Challenges
      • 3.3.1. Detection of disease at an early stage helps not only to reduce the cost of medical treatment but is also useful in saving valuable lives of people
    • 3.4. Market Trends
      • 3.4.1. Rising demand for e-health application
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Healthcare and Medical Simulation, by Category, Industry Vertical, End Use and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Healthcare and Medical Simulation (Value)
      • 5.2.1. Global Healthcare and Medical Simulation by: Category (Value)
        • 5.2.1.1. Low-fidelity simulators
        • 5.2.1.2. Medium-fidelity simulators
        • 5.2.1.3. High-fidelity simulators
      • 5.2.2. Global Healthcare and Medical Simulation by: Industry Vertical (Value)
        • 5.2.2.1. Military
        • 5.2.2.2. Commercial airlines
        • 5.2.2.3. Nuclear power plants
        • 5.2.2.4. Business and medicine
        • 5.2.2.5. Others
      • 5.2.3. Global Healthcare and Medical Simulation by: End Use (Value)
        • 5.2.3.1. Pediatricians
        • 5.2.3.2. Pediatric subspecialists
        • 5.2.3.3. Pediatric nurses
        • 5.2.3.4. Educators
        • 5.2.3.5. Others
      • 5.2.4. Global Healthcare and Medical Simulation Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Australia
          • 5.2.4.2.6. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Healthcare and Medical Simulation (Price)
  • 6. Healthcare and Medical Simulation: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. MedAffinity (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Laerdal (Norway)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Kyoto Kagaku Co., Ltd (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Gaumard (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. MedVision (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Limbs and things (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. KbPort LLC (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. International Pediatric Simulation Society (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. DiaMedical (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Simulab Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Ford Audio-Video (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Medical-X (Netherlands)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. CAE Healthcare (Canada)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. AUGMENT SIMULATION (Canada)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Intelligent Ultrasound (United Kingdom)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Nasco Healthcare (United States)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
      • 6.4.17. Others
        • 6.4.17.1. Business Overview
        • 6.4.17.2. Products/Services Offerings
        • 6.4.17.3. Financial Analysis
        • 6.4.17.4. SWOT Analysis
  • 7. Global Healthcare and Medical Simulation Sale, by Category, Industry Vertical, End Use and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Healthcare and Medical Simulation (Value)
      • 7.2.1. Global Healthcare and Medical Simulation by: Category (Value)
        • 7.2.1.1. Low-fidelity simulators
        • 7.2.1.2. Medium-fidelity simulators
        • 7.2.1.3. High-fidelity simulators
      • 7.2.2. Global Healthcare and Medical Simulation by: Industry Vertical (Value)
        • 7.2.2.1. Military
        • 7.2.2.2. Commercial airlines
        • 7.2.2.3. Nuclear power plants
        • 7.2.2.4. Business and medicine
        • 7.2.2.5. Others
      • 7.2.3. Global Healthcare and Medical Simulation by: End Use (Value)
        • 7.2.3.1. Pediatricians
        • 7.2.3.2. Pediatric subspecialists
        • 7.2.3.3. Pediatric nurses
        • 7.2.3.4. Educators
        • 7.2.3.5. Others
      • 7.2.4. Global Healthcare and Medical Simulation Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Australia
          • 7.2.4.2.6. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Healthcare and Medical Simulation (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Healthcare and Medical Simulation: by Category(USD Million)
  • Table 2. Healthcare and Medical Simulation Low-fidelity simulators , by Region USD Million (2015-2020)
  • Table 3. Healthcare and Medical Simulation Medium-fidelity simulators , by Region USD Million (2015-2020)
  • Table 4. Healthcare and Medical Simulation High-fidelity simulators , by Region USD Million (2015-2020)
  • Table 5. Healthcare and Medical Simulation: by Industry Vertical(USD Million)
  • Table 6. Healthcare and Medical Simulation Military , by Region USD Million (2015-2020)
  • Table 7. Healthcare and Medical Simulation Commercial airlines , by Region USD Million (2015-2020)
  • Table 8. Healthcare and Medical Simulation Nuclear power plants , by Region USD Million (2015-2020)
  • Table 9. Healthcare and Medical Simulation Business and medicine , by Region USD Million (2015-2020)
  • Table 10. Healthcare and Medical Simulation Others , by Region USD Million (2015-2020)
  • Table 11. Healthcare and Medical Simulation: by End Use(USD Million)
  • Table 12. Healthcare and Medical Simulation Pediatricians , by Region USD Million (2015-2020)
  • Table 13. Healthcare and Medical Simulation Pediatric subspecialists , by Region USD Million (2015-2020)
  • Table 14. Healthcare and Medical Simulation Pediatric nurses , by Region USD Million (2015-2020)
  • Table 15. Healthcare and Medical Simulation Educators , by Region USD Million (2015-2020)
  • Table 16. Healthcare and Medical Simulation Others , by Region USD Million (2015-2020)
  • Table 17. South America Healthcare and Medical Simulation, by Country USD Million (2015-2020)
  • Table 18. South America Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 19. South America Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 20. South America Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 21. Brazil Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 22. Brazil Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 23. Brazil Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 24. Argentina Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 25. Argentina Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 26. Argentina Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 27. Rest of South America Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 28. Rest of South America Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 29. Rest of South America Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 30. Asia Pacific Healthcare and Medical Simulation, by Country USD Million (2015-2020)
  • Table 31. Asia Pacific Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 32. Asia Pacific Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 33. Asia Pacific Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 34. China Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 35. China Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 36. China Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 37. Japan Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 38. Japan Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 39. Japan Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 40. India Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 41. India Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 42. India Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 43. South Korea Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 44. South Korea Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 45. South Korea Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 46. Australia Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 47. Australia Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 48. Australia Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 52. Europe Healthcare and Medical Simulation, by Country USD Million (2015-2020)
  • Table 53. Europe Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 54. Europe Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 55. Europe Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 56. Germany Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 57. Germany Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 58. Germany Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 59. France Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 60. France Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 61. France Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 62. Italy Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 63. Italy Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 64. Italy Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 65. United Kingdom Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 66. United Kingdom Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 67. United Kingdom Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 68. Netherlands Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 69. Netherlands Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 70. Netherlands Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 71. Rest of Europe Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 72. Rest of Europe Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 73. Rest of Europe Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 74. MEA Healthcare and Medical Simulation, by Country USD Million (2015-2020)
  • Table 75. MEA Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 76. MEA Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 77. MEA Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 78. Middle East Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 79. Middle East Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 80. Middle East Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 81. Africa Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 82. Africa Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 83. Africa Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 84. North America Healthcare and Medical Simulation, by Country USD Million (2015-2020)
  • Table 85. North America Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 86. North America Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 87. North America Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 88. United States Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 89. United States Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 90. United States Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 91. Canada Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 92. Canada Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 93. Canada Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 94. Mexico Healthcare and Medical Simulation, by Category USD Million (2015-2020)
  • Table 95. Mexico Healthcare and Medical Simulation, by Industry Vertical USD Million (2015-2020)
  • Table 96. Mexico Healthcare and Medical Simulation, by End Use USD Million (2015-2020)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Healthcare and Medical Simulation: by Category(USD Million)
  • Table 115. Healthcare and Medical Simulation Low-fidelity simulators , by Region USD Million (2021-2026)
  • Table 116. Healthcare and Medical Simulation Medium-fidelity simulators , by Region USD Million (2021-2026)
  • Table 117. Healthcare and Medical Simulation High-fidelity simulators , by Region USD Million (2021-2026)
  • Table 118. Healthcare and Medical Simulation: by Industry Vertical(USD Million)
  • Table 119. Healthcare and Medical Simulation Military , by Region USD Million (2021-2026)
  • Table 120. Healthcare and Medical Simulation Commercial airlines , by Region USD Million (2021-2026)
  • Table 121. Healthcare and Medical Simulation Nuclear power plants , by Region USD Million (2021-2026)
  • Table 122. Healthcare and Medical Simulation Business and medicine , by Region USD Million (2021-2026)
  • Table 123. Healthcare and Medical Simulation Others , by Region USD Million (2021-2026)
  • Table 124. Healthcare and Medical Simulation: by End Use(USD Million)
  • Table 125. Healthcare and Medical Simulation Pediatricians , by Region USD Million (2021-2026)
  • Table 126. Healthcare and Medical Simulation Pediatric subspecialists , by Region USD Million (2021-2026)
  • Table 127. Healthcare and Medical Simulation Pediatric nurses , by Region USD Million (2021-2026)
  • Table 128. Healthcare and Medical Simulation Educators , by Region USD Million (2021-2026)
  • Table 129. Healthcare and Medical Simulation Others , by Region USD Million (2021-2026)
  • Table 130. South America Healthcare and Medical Simulation, by Country USD Million (2021-2026)
  • Table 131. South America Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 132. South America Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 133. South America Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 134. Brazil Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 135. Brazil Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 136. Brazil Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 137. Argentina Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 138. Argentina Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 139. Argentina Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 140. Rest of South America Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 141. Rest of South America Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 142. Rest of South America Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 143. Asia Pacific Healthcare and Medical Simulation, by Country USD Million (2021-2026)
  • Table 144. Asia Pacific Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 145. Asia Pacific Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 146. Asia Pacific Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 147. China Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 148. China Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 149. China Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 150. Japan Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 151. Japan Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 152. Japan Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 153. India Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 154. India Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 155. India Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 156. South Korea Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 157. South Korea Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 158. South Korea Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 159. Australia Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 160. Australia Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 161. Australia Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 162. Rest of Asia-Pacific Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 163. Rest of Asia-Pacific Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 164. Rest of Asia-Pacific Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 165. Europe Healthcare and Medical Simulation, by Country USD Million (2021-2026)
  • Table 166. Europe Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 167. Europe Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 168. Europe Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 169. Germany Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 170. Germany Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 171. Germany Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 172. France Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 173. France Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 174. France Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 175. Italy Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 176. Italy Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 177. Italy Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 178. United Kingdom Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 179. United Kingdom Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 180. United Kingdom Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 181. Netherlands Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 182. Netherlands Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 183. Netherlands Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 184. Rest of Europe Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 185. Rest of Europe Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 186. Rest of Europe Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 187. MEA Healthcare and Medical Simulation, by Country USD Million (2021-2026)
  • Table 188. MEA Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 189. MEA Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 190. MEA Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 191. Middle East Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 192. Middle East Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 193. Middle East Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 194. Africa Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 195. Africa Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 196. Africa Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 197. North America Healthcare and Medical Simulation, by Country USD Million (2021-2026)
  • Table 198. North America Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 199. North America Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 200. North America Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 201. United States Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 202. United States Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 203. United States Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 204. Canada Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 205. Canada Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 206. Canada Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 207. Mexico Healthcare and Medical Simulation, by Category USD Million (2021-2026)
  • Table 208. Mexico Healthcare and Medical Simulation, by Industry Vertical USD Million (2021-2026)
  • Table 209. Mexico Healthcare and Medical Simulation, by End Use USD Million (2021-2026)
  • Table 210. Research Programs/Design for This Report
  • Table 211. Key Data Information from Secondary Sources
  • Table 212. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Healthcare and Medical Simulation: by Category USD Million (2015-2020)
  • Figure 5. Global Healthcare and Medical Simulation: by Industry Vertical USD Million (2015-2020)
  • Figure 6. Global Healthcare and Medical Simulation: by End Use USD Million (2015-2020)
  • Figure 7. South America Healthcare and Medical Simulation Share (%), by Country
  • Figure 8. Asia Pacific Healthcare and Medical Simulation Share (%), by Country
  • Figure 9. Europe Healthcare and Medical Simulation Share (%), by Country
  • Figure 10. MEA Healthcare and Medical Simulation Share (%), by Country
  • Figure 11. North America Healthcare and Medical Simulation Share (%), by Country
  • Figure 12. Global Healthcare and Medical Simulation share by Players 2020 (%)
  • Figure 13. Global Healthcare and Medical Simulation share by Players (Top 3) 2020(%)
  • Figure 14. Global Healthcare and Medical Simulation share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. MedAffinity (United States) Revenue, Net Income and Gross profit
  • Figure 17. MedAffinity (United States) Revenue: by Geography 2020
  • Figure 18. Laerdal (Norway) Revenue, Net Income and Gross profit
  • Figure 19. Laerdal (Norway) Revenue: by Geography 2020
  • Figure 20. Kyoto Kagaku Co., Ltd (China) Revenue, Net Income and Gross profit
  • Figure 21. Kyoto Kagaku Co., Ltd (China) Revenue: by Geography 2020
  • Figure 22. Gaumard (United States) Revenue, Net Income and Gross profit
  • Figure 23. Gaumard (United States) Revenue: by Geography 2020
  • Figure 24. MedVision (Germany) Revenue, Net Income and Gross profit
  • Figure 25. MedVision (Germany) Revenue: by Geography 2020
  • Figure 26. Limbs and things (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. Limbs and things (United Kingdom) Revenue: by Geography 2020
  • Figure 28. KbPort LLC (United States) Revenue, Net Income and Gross profit
  • Figure 29. KbPort LLC (United States) Revenue: by Geography 2020
  • Figure 30. International Pediatric Simulation Society (United States) Revenue, Net Income and Gross profit
  • Figure 31. International Pediatric Simulation Society (United States) Revenue: by Geography 2020
  • Figure 32. DiaMedical (United States) Revenue, Net Income and Gross profit
  • Figure 33. DiaMedical (United States) Revenue: by Geography 2020
  • Figure 34. Simulab Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 35. Simulab Corporation (United States) Revenue: by Geography 2020
  • Figure 36. Ford Audio-Video (United States) Revenue, Net Income and Gross profit
  • Figure 37. Ford Audio-Video (United States) Revenue: by Geography 2020
  • Figure 38. Medical-X (Netherlands) Revenue, Net Income and Gross profit
  • Figure 39. Medical-X (Netherlands) Revenue: by Geography 2020
  • Figure 40. CAE Healthcare (Canada) Revenue, Net Income and Gross profit
  • Figure 41. CAE Healthcare (Canada) Revenue: by Geography 2020
  • Figure 42. AUGMENT SIMULATION (Canada) Revenue, Net Income and Gross profit
  • Figure 43. AUGMENT SIMULATION (Canada) Revenue: by Geography 2020
  • Figure 44. Intelligent Ultrasound (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 45. Intelligent Ultrasound (United Kingdom) Revenue: by Geography 2020
  • Figure 46. Nasco Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 47. Nasco Healthcare (United States) Revenue: by Geography 2020
  • Figure 48. Others Revenue, Net Income and Gross profit
  • Figure 49. Others Revenue: by Geography 2020
  • Figure 50. Global Healthcare and Medical Simulation: by Category USD Million (2021-2026)
  • Figure 51. Global Healthcare and Medical Simulation: by Industry Vertical USD Million (2021-2026)
  • Figure 52. Global Healthcare and Medical Simulation: by End Use USD Million (2021-2026)
  • Figure 53. South America Healthcare and Medical Simulation Share (%), by Country
  • Figure 54. Asia Pacific Healthcare and Medical Simulation Share (%), by Country
  • Figure 55. Europe Healthcare and Medical Simulation Share (%), by Country
  • Figure 56. MEA Healthcare and Medical Simulation Share (%), by Country
  • Figure 57. North America Healthcare and Medical Simulation Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • MedAffinity (United States)
  • Laerdal (Norway)
  • Kyoto Kagaku Co., Ltd (China)
  • Gaumard (United States)
  • MedVision (Germany)
  • Limbs and things (United Kingdom)
  • KbPort LLC (United States)
  • International Pediatric Simulation Society (United States)
  • DiaMedical (United States)
  • Simulab Corporation (United States)
  • Ford Audio-Video (United States)
  • Medical-X (Netherlands)
  • CAE Healthcare (Canada)
  • AUGMENT SIMULATION (Canada)
  • Intelligent Ultrasound (United Kingdom)
  • Nasco Healthcare (United States)
  • Others
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation